Experiment 927385
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | DILLMAN,RO: MICK,R: MC INTYRE,OR:. (1989). PENTOSTATIN IN CHRONIC LYMPHOCYTIC LEUKEMIA: A PHASE II TRIAL OF CANCER AND LEUKEMIA GROUP B.. 17(4) |
| Amount utilized | |
| Compound isolated | |
| Disease | 39 PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WERE USED IN THIS PHASE II STUDY. THERE WAS 1 COMPLETE REMISSION, 9 PARTIAL REMISSIONS, 11 CLINICAL IMPROVEMENTS, 15 STABLE DISEASE AND 3 UNAVAILABLE. PREDOMINANT TOXICITIES WERE INFECTIONS OF GRADE 2 OR WORSE IN 52% OF PATIENTS, WORSENING OF THROMBOCYTOPENIA OR ANEMIA, NAUSEA AND VOMITING. RASH AND PURITIS WAS ALSO SEEN IN 20% OF PATIENTS. DOSE WAS GIVEN DAILY FOR 3 WKS, AND THEN EVERY 2 WKS. |
| Dose amount | 4.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |